APA (7th ed.) Citation

Caixia Deng, Hu Luo, & Xiangdong Zhou. (2018). Response to first-line erlotinib in a false EGFR mutation-negative patient with non-small-cell lung cancer: Make no assumptions. Open Journal of Cell and Protein Science - Peertechz Publications. https://doi.org/10.17352/ojcps.000001

Chicago Style (17th ed.) Citation

Caixia Deng, Hu Luo, and Xiangdong Zhou. Response to First-line Erlotinib in a False EGFR Mutation-negative Patient with Non-small-cell Lung Cancer: Make No Assumptions. Open Journal of Cell and Protein Science - Peertechz Publications, 2018. https://doi.org/10.17352/ojcps.000001.

MLA (9th ed.) Citation

Caixia Deng, et al. Response to First-line Erlotinib in a False EGFR Mutation-negative Patient with Non-small-cell Lung Cancer: Make No Assumptions. Open Journal of Cell and Protein Science - Peertechz Publications, 2018. https://doi.org/10.17352/ojcps.000001.